Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Biohaven Ltd
(NY:
BHVN
)
36.51
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, May 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Biohaven Ltd
< Previous
1
2
3
4
5
6
7
Next >
12 Health Care Stocks Moving In Monday's Intraday Session
October 10, 2022
Gainers
Via
Benzinga
Coinbase Global And 3 Other Stocks Insiders Are Buying
October 07, 2022
Although US stocks closed lower on Thursday, there were a few notable insider trades.
Via
Benzinga
Biohaven Ltd. Surges 7.6%: Is This An Indication Of Further Gains?
October 07, 2022
Biohaven Ltd. shares ended the last trading session 7.6% higher at $13.18. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares...
Via
Talk Markets
Pinterest, Perion Network And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
October 06, 2022
U.S. stock futures traded lower this morning. Here are some big stocks recording gains in today’s pre-market trading session.
Via
Benzinga
Why WISeKey International Is Trading Higher By Over 20%; Here Are 29 Stocks Moving Premarket
October 06, 2022
Gainers Statera Biopharma, Inc. (NASDAQ: STAB) rose 89.4% to $0.2655 in pre-market trading. Statera Biopharma was recently granted European patent number EP3206708 titled "Methods And Compositions For...
Via
Benzinga
Recap: Biohaven Pharma Hldgs Q2 Earnings
August 05, 2022
Biohaven Pharma Hldgs (NYSE:BHVN) reported its Q2 earnings results on Friday, August 5, 2022 at 07:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Why Nauticus Robotics Shares Are Trading Higher By 96%; Here Are 67 Biggest Movers From Yesterday
October 06, 2022
Gainers Chardan NexTech Acquisition 2 Corp. (NASDAQ: CNTQ) shares surged 102.6% to close at $21.54 on Wednesday.
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
October 04, 2022
On Tuesday, 44 companies hit new 52-week lows.
Via
Benzinga
Biohaven's Neurological Disease Candidate Flunks In Late-Stage Study
May 23, 2022
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
October 04, 2022
Gainers Avenue Therapeutics (NASDAQ:ATXI) shares moved upwards by 37.7% to $15.85 during Tuesday's pre-market session. The company's market cap stands at $23.3 million.
Via
Benzinga
IPO Scorcher Amylyx Wins FDA Approval In ALS Treatment, Ending A Long Battle
September 29, 2022
The drug has faced two advisory committees and a delayed review date.
Via
Investor's Business Daily
Biohaven's ALS Drug Fails To Meet Study Endpoint, Second Therapy To Fail Trials In Recent Months
September 29, 2022
Biohaven Pharmaceutical Holding Company Ltd (NASDAQ: BHVN) announced results from a focused analysis of verdiperstat in the HEALEY ALS Platform Trial in amyotrophic lateral sclerosis (ALS).
Via
Benzinga
Top-Notch Biohaven Pharmaceutical Stock Trips As ALS Drug Flops In Key Test
September 29, 2022
Patients didn't show any improvements in a study meant to test multiple drugs.
Via
Investor's Business Daily
Stocks That Hit 52-Week Highs On Friday
September 23, 2022
On Friday, 5 companies hit new 52-week highs.
Via
Benzinga
Something Unusual Is Happening Right Now With Biotech Stocks Like Catalyst, Vertex, Neurocrine And BioMarin
September 15, 2022
The market is struggling, yet biotech stocks are acting like it's good times again. Here's why.
Via
Investor's Business Daily
Biohaven Pharmaceutical's Return On Capital Employed Overview
August 26, 2022
Benzinga Pro data, Biohaven Pharmaceutical (NYSE:BHVN) reported Q2 sales of $215.08 million. Earnings fell to a loss of $441.88 million, resulting in a 278.01% decrease from last quarter.
Via
Benzinga
$5.6 Million Bet On This Healthcare Stock? 3 Stocks Insiders Are Buying
August 23, 2022
Although US stocks closed sharply lower on Monday, there were a few notable insider trades.
Via
Benzinga
Freedom Biosciences Gets $10.5M In Seed Financing For Psychedelics Research, This Is What We Know
August 23, 2022
Freedom Biosciences achieved a major $10.5 million in a seed financing round in which MBX Capital, PsyMed Ventures, Village Global and The Yale Startup, among others, participated.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 19, 2022
August 19, 2022
Upgrades
Via
Benzinga
Why These Pfizer Analysts Like The Global Blood Therapeutics Deal
August 08, 2022
Pfizer Inc. (NYSE: PFE) shares were trading lower Monday after the drugmaker announced a $5.4-billion bid to acquire blood disorder drugmaker Global Blood Therapeutics Inc (NASDAQ: GBT).
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2022
August 08, 2022
Via
Benzinga
Pfizer Is Reportedly In 'Advanced Talks' To Buy Global Blood Therapeutics For $5 Billion
August 05, 2022
Shares of Pfizer's rumored takeover target have rocketed for two days running.
Via
Investor's Business Daily
The 3 Best Market Sectors for the Second Half of 2022
July 27, 2022
Compelling themes will drive a recovery in some sectors over the second half of 2022. The following are the best market sectors to buy into.
Via
InvestorPlace
Which Coronavirus Stock Could Fetch Higher Returns?
July 11, 2022
This article will compare Pfizer, Moderna, and Novavax to see which of these coronavirus stocks will yield the highest returns.
Via
InvestorPlace
Is Pfizer Stock A Buy Or A Sell As Its Covid Vaccine Faces A New Lawsuit?
July 05, 2022
The FDA's advisors recently backed Pfizer's Covid shot for young children.
Via
Investor's Business Daily
Hopeful Golden Cross Forms On Biohaven Pharma Hldgs's Chart
June 23, 2022
If history is any guide, there may be good fortune ahead for shares of Biohaven Pharma Hldgs (NYSE:BHVN). A so-called "golden cross" has formed on its chart and, not surprisingly, this could be bullish...
Via
Benzinga
Looking Into Biohaven Pharmaceutical's Return On Capital Employed
June 10, 2022
According to data from Benzinga Pro, during Q1, Biohaven Pharmaceutical's (NYSE:BHVN) reported sales totaled $318.85 million. Despite a 41.43% increase in earnings, the company posted a loss of $116.90...
Via
Benzinga
3 Biotech Stocks to Buy Before They Boom
June 01, 2022
It could be a “never-before, never-after opportunity” to buy into these biotech stocks that trade at very attractive valuations.
Via
InvestorPlace
Pfizer's Nearly $7 Billion Acquisition Of Arena Pharma Just Paid Off In A Big Way
May 24, 2022
The company is planning to soon ask for FDA approval of etrasimod in ulcerative colitis.
Via
Investor's Business Daily
The Week Ahead In Biotech: Gene & Cell Therapy Conference, Tapering Earnings News, OKYO Pharma IPO And More
May 16, 2022
Biopharma stocks remained largely unchanged in the week ending May 13, with the defensive nature of the sector coming to its aid. Stocks reacted to the broader market move and earnings news from...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.